Human enteropeptidase-IN-1

Modify Date: 2024-01-28 11:12:42

Human enteropeptidase-IN-1 Structure
Human enteropeptidase-IN-1 structure
Common Name Human enteropeptidase-IN-1
CAS Number 1802891-23-1 Molecular Weight 426.38
Density N/A Boiling Point N/A
Molecular Formula C20H18N4O7 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Human enteropeptidase-IN-1


Human enteropeptidase-IN-1 (compound 6b) is a highly potent, orally active and low systemic exposure enteropeptidase inhibitor. Human enteropeptidase-IN-1 boosts the increase in fecal protein output, and exhibits potent body weight loss in diet-induced obese (DIO) rat model. Human enteropeptidase-IN-1 can be used for anti-obesity research[1].

 Names

Name Human enteropeptidase-IN-1

 Human enteropeptidase-IN-1 Biological Activity

Description Human enteropeptidase-IN-1 (compound 6b) is a highly potent, orally active and low systemic exposure enteropeptidase inhibitor. Human enteropeptidase-IN-1 boosts the increase in fecal protein output, and exhibits potent body weight loss in diet-induced obese (DIO) rat model. Human enteropeptidase-IN-1 can be used for anti-obesity research[1].
Related Catalog
Target

IC50(initial): 20 nM (enteropeptidase)[1] IC50(app): 1.2 nM (enteropeptidase)[1]

In Vitro Human enteropeptidase-IN-1 (compound 6b) has inhibitory activity against enteropeptidase with IC50(initial)* of 20 nM and IC50(app)** of 1.2 nM[1]. (*IC50(initial) refers to the inhibitory activity of human enteropeptidase after 6 min of incubation with the enzyme, substrate, and compound. **IC50(app) refers to the apparent IC50 value after 120 min of incubation with the enzyme, substrate, and compound.)
References

[1]. Ikeda Z, et al. Design, Synthesis, and Biological Evaluation of a Novel Series of 4-Guanidinobenzoate Derivatives as Enteropeptidase Inhibitors with Low Systemic Exposure for the Treatment of Obesity. J Med Chem. 2022 Jun 23;65(12):8456-8477.

 Chemical & Physical Properties

Molecular Formula C20H18N4O7
Molecular Weight 426.38